SHOULDER INNOVATIONS, INC. (SI)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch SI
See up to 3 months of SI. The 7-day demo opens the 1M and 3M ranges and puts SI on your watchlist.
Start 7-day demoLatest SI insider trades
About SHOULDER INNOVATIONS, INC. (SI)
SHOULDER INNOVATIONS, INC. files with the SEC under CIK 0001699350 and is classified as surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
SI Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 14 | 227,243 | $5.09M |
| Grant or award | 4 | 3,569 | |
| Option exercise | 2 | 178,466 | |
SI insider transactions (Form 4)
6143 Form 4 filings on record, the earliest from Aug 1, 2025, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Casey M. Tansey - Director | Grant or award | Common Stock | 733 footnote F1 | $19.60 | $14K | |
| ||||||
| Kevin K. Sidow - Director | Grant or award | Common Stock | 892 footnote F1 | $19.60 | $17K | |
| ||||||
| Andrew Hykes - Director | Grant or award | Common Stock | 669 footnote F1 | $19.60 | $13K | |
| ||||||
| Paul Buckman - Director | Grant or award | Common Stock | 1,275 footnote F1 | $19.60 | $25K | |
| ||||||
| Robert Joseph Ball - Officer | Option exercise | Common Stock | 89,233 | $2.10 | $187K | |
| Robert Joseph Ball - Officer | Open-market sale | Common Stock | 10,175 | $18.45 footnote F2 | $188K | |
| Robert Joseph Ball - Officer | Option exercise | Stock Option | 89,233 | $0.00 | - | |
| ||||||
| Gilde Healthcare Holding B.V. - 10% Owner | Open-market sale | Common Stock | 1,196 | $22.60 | $27K | |
| Gilde Healthcare Holding B.V. - 10% Owner | Open-market sale | Common Stock | 3,900 | $22.60 | $88K | |
| Gilde Healthcare Holding B.V. - 10% Owner | Open-market sale | Common Stock | 20,516 | $22.61 footnote F2 | $464K | |
| Gilde Healthcare Holding B.V. - 10% Owner | Open-market sale | Common Stock | 681 | $22.62 footnote F3 | $15K | |
| ||||||
| Matthew Fraser Ahearn - Officer | Gift | Common Stock | 2,500 | $0.00 | - | |
| Matthew Fraser Ahearn - Officer | Open-market sale | Common Stock | 8,314 | $20.10 footnote F2 | $167K | |
| Matthew Fraser Ahearn - Officer | Open-market sale | Common Stock | 12,586 | $20.94 footnote F3 | $263K | |
| Matthew Fraser Ahearn - Officer | Open-market sale | Common Stock | 1,600 | $21.38 footnote F4 | $34K | |
| ||||||
| Gilde Healthcare Holding B.V. - 10% Owner | Open-market sale | Common Stock | 7,338 | $22.64 footnote F1 | $166K | |
| Gilde Healthcare Holding B.V. - 10% Owner | Open-market sale | Common Stock | 2,095 | $22.60 | $47K | |
| ||||||
| Gilde Healthcare Holding B.V. - 10% Owner | Open-market sale | Common Stock | 10,751 | $22.71 footnote F1 | $244K | |
| Gilde Healthcare Holding B.V. - 10% Owner | Open-market sale | Common Stock | 99,812 | $22.77 footnote F3 | $2.27M | |
| ||||||
| Gilde Healthcare Holding B.V. - 10% Owner | Open-market sale | Common Stock | 28,245 | $23.36 footnote F1 | $660K | |
| Gilde Healthcare Holding B.V. - 10% Owner | Open-market sale | Common Stock | 20,034 | $22.73 footnote F3 | $455K | |
| ||||||
| Casey M. Tansey - Director | Grant or award | Common Stock | 5,046 footnote F1 | $0.00 | - | |
| ||||||
| Kevin K. Sidow - Director | Grant or award | Common Stock | 5,046 footnote F1 | $0.00 | - | |
| ||||||
| Andrew Hykes - Director | Grant or award | Common Stock | 5,046 footnote F1 | $0.00 | - | |
| ||||||
| Paul Buckman - Director | Grant or award | Common Stock | 5,046 footnote F1 | $0.00 | - | |
| ||||||
| Richard Buchholz - Director | Grant or award | Common Stock | 5,046 footnote F1 | $0.00 | - | |
| ||||||
| Matthew Fraser Ahearn - Officer | Open-market sale | Common Stock | 15,856 | $18.68 footnote F2 | $296K | |
| Matthew Fraser Ahearn - Officer | Open-market sale | Common Stock | 1,644 | $18.20 footnote F4 | $30K | |
| Matthew Fraser Ahearn - Officer | Open-market sale | Common Stock | 2,500 | $19.26 footnote F5 | $48K | |
| ||||||
| Matthew Fraser Ahearn - Officer | Option exercise | Common Stock | 14,243 | $2.86 | $41K | |
| Matthew Fraser Ahearn - Officer | Option exercise | Common Stock | 7,421 | $2.48 | $18K | |
| Matthew Fraser Ahearn - Officer | Option exercise | Stock Option | 7,421 | $0.00 | - | |
| Matthew Fraser Ahearn - Officer | Option exercise | Stock Option | 14,243 | $0.00 | - | |
| Jeffrey S. Points - Officer | Option exercise | Common Stock | 13,264 | $2.48 | $33K | |
| Jeffrey S. Points - Officer | Open-market purchase | Common Stock | 2,000 | $15.00 | $30K | |
| Jeffrey S. Points - Officer | Option exercise | Stock Option | 13,264 | $0.00 | - | |
| Paul Buckman - Director | Option exercise | Common Stock | 26,205 | $2.10 | $55K | |
| Paul Buckman - Director | Tax withholding / forfeiture | Common Stock | 3,292 | $14.62 | $48K | |
| Paul Buckman - Director | Tax withholding / forfeiture | Common Stock | 3,714 | $14.82 | $55K | |
| Paul Buckman - Director | Option exercise | Common Stock | 19,401 | $2.48 | $48K | |
| Paul Buckman - Director | Option exercise | Stock Option | 19,401 | $0.00 | - | |
| Paul Buckman - Director | Option exercise | Stock Option | 26,205 | $0.00 | - | |
| Richard Buchholz - Director | Open-market purchase | Common Stock | 1,000 | $14.84 | $15K | |
| Robert Joseph Ball - Officer | Open-market purchase | Common Stock | 2,200 | $15.18 footnote F1 | $33K | |
| ||||||
| Robert Joseph Ball - Officer | Option exercise | Common Stock | 2,062 | $2.10 | $4K | |
| Robert Joseph Ball - Officer | Option exercise | Common Stock | 10,000 | $2.48 | $25K | |
| Robert Joseph Ball - Officer | Option exercise | Stock Option | 10,000 | $0.00 | - | |
| Robert Joseph Ball - Officer | Option exercise | Stock Option | 2,062 | $0.00 | - | |
| Jeffrey S. Points - Officer | Grant or award | Stock Option | 126,357 | $0.00 | - | |
| David Lawrence Blue - Officer | Grant or award | Stock Option | 88,450 | $0.00 | - | |
| Robert Joseph Ball - Officer | Grant or award | Stock Option | 265,351 | $0.00 | - | |
| Matthew Fraser Ahearn - Officer | Grant or award | Stock Option | 88,450 | $0.00 | - | |
| Jeffrey S. Points - Officer | Option exercise | Common Stock | 13,264 | $2.48 | $33K | |
| Jeffrey S. Points - Officer | Open-market purchase | Common Stock | 1,600 | $15.67 | $25K | |
| Jeffrey S. Points - Officer | Option exercise | Stock Option | 13,264 | $0.00 | - | |
| Robert Joseph Ball - Officer | Open-market purchase | Common Stock | 2,000 | $14.90 | $30K | |
| Robert Joseph Ball - Officer | Open-market purchase | Common Stock | 6,000 | $15.49 | $93K | |
| David Lawrence Blue - Officer | Option exercise | Common Stock | 78,616 | $2.10 | $165K | |
| David Lawrence Blue - Officer | Option exercise | Common Stock | 15,778 | $2.48 | $39K | |
| David Lawrence Blue - Officer | Option exercise | Stock Option | 78,616 | $0.00 | - | |
| David Lawrence Blue - Officer | Option exercise | Stock Option | 15,778 | $0.00 | - | |
Item 7.01, 9.01
Item 7.01, 9.01
Item 2.02, 9.01
Item 1.01, 1.02, 2.03, 7.01, 9.01
Recent SI Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| ROBERT BALL | Officer, Director | 10,175 | $188K | View on EDGAR | |
| MATTHEW AHEARN | Director, Officer | 22,500 |
SI insider trading FAQ
What is the latest insider trade for SI?
SHOULDER INNOVATIONS, INC. (SI) had 11 insider filings in the last 90 days, with the most recent on 2026-10-06. The full record for SI runs to 43 Form 4 filings, the earliest from 2025-08-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SI stock?
No insider purchases of SI were filed in the last 90 days. 13 purchases are on record for this company.
How many insiders are selling SI stock?
14 insider sales of SI were filed in the last 90 days, totaling $5.09M.
Where can I see SI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Casey M. Tansey view on EDGAR
- - Kevin K. Sidow view on EDGAR
- - Andrew Hykes view on EDGAR
- - Paul Buckman view on EDGAR
- - Robert Joseph Ball view on EDGAR
- - Gilde Healthcare Holding B.V. view on EDGAR
- - Gilde Healthcare Holding B.V. view on EDGAR
- - Matthew Fraser Ahearn view on EDGAR
- - Gilde Healthcare Holding B.V. view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where SI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SI with a 7-day demo
- SI on your watchlist
- Every SI Form 4 filing on record
- Up to 3 months of SI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
